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Summary Current practice and outcome for patients with lung cancer were determined by retrospective case note review of a random sample
of all lung cancer cases registered for a calendar year and augmented by review of all surgical and radical radiotherapy cases. A total of 262
patients - 231 patients less than 75 years of age and 31 patients more than 75 years of age - represented 83% of the random sample. Eighty-
three per cent of patients were seen within 2 weeks of referral. One-third reported symptoms occurring for less than 1 month and one-third
had experienced symptoms for more than 3 months. The median time interval from first hospital contact until the making of a management
decision was 18 days. The median interval from first contact to surgery was 63 days, and to starting radical radiotherapy 70 days. Histological
confirmation was obtained in 69% of patients. Ten per cent of all lung cancer patients were calculated to have received chemotherapy. Five
per cent of the whole cohort had definitive surgery and 64% of these were judged to be free of the disease at 3 years. Overall survival was 9%
at 3 years, with no differences relating to cell type or area of residence. Many areas of good practice have been identified. but the lack of
tumour staging or performance status data, the low proportion receiving chemotherapy or definitive surgery and the poor outcome after
radical radiotherapy indicate the need for prospective audit and feedback of results. The long time interval from management decision to
surgery and radiotherapy suggests organizational issues which need attention.
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Lung cancer is a leading cause of death in Scotland. rankinu third
after ischaemic heart disease and cerebroxascular disease as the
cause of death in men (Scottish Health Statistics. 1994). In
Glasaowx. the incidence oflung cancer is more than 30%c above the
Scottish axverage. A review of clinical practice was undertaken to
determine local practice and identify resources utilized by this
significant group of patients.
METHODS
Study population
The cancer registrv held within the West of Scotland Cancer
Surveillance Unit xwas used to identify Greater Glasgow residents
reuistered wxith a primary diagnosis oflung cancer between 1 June
1991 and 31 Mav 1992. In xiew of the areater numbers of older
patients. a random sample of one in three cases under 75 years of
aae and one in sexen agyed 75 and over x as made.
This random sample w-as supplemented by studying all cases
undergoing surgery or receixing radical radiotherapy. Such
patients were identified in collaboration with the relevant special-
ists. The socioeconomic structure of the study population was
determined bx area of residence at the time of diagnosis. as
recorded in patients case records (Carstairs and Morris. 1991).
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Exclusions
One thousand two hundred and sexenteen (12171 registrations
were recorded during the study period. Sexenty-fixve (6S%) xxere
registered on the basis ofdeath certificate only and were excluded.
as no management decisions could haxe been made. leaxving a
study cohort of 1142.
Data collection
Data were collected by retrospectixe case note rexviexx. including
details of: (1) time intervals measured in actual days. betxeen
referral. hospital contact. management decision and treatment -
letter dates wxere used throughout. the final date beinc taken x here
a letter had been dictated and. for example. signed on a different
stated date: (2) clinical specialty of those inxolxed in initial
management and treatment decisions: (3) expensixe resources
utilized in the diagnosis and initial management: (4) histological
confirmation rates and distribution of cell types: (5) actual initial
management.
Permission to rexiex case notes was obtained from all consul-
tants in charge of patients in the study. Data wxere collected by a
nurse (EK) and a respiratory physician (CEB). Survixal data xere
obtained from the cancer registrx and calculated for each patient
up to 3 years after diagnosis.
Statistics
Data management and analy sis were performed using SPSS PC
and Epi-info V6. Survix al analy ses x ere carried out usinu
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Kaplan-Meier methods (Armitage and Berry. 1994) and chi-
square tests x ere performed for comparison ofcategorical data.
RESULTS
Eight hundred and six patients under 75 years of age and 336
patients oxer 75 wxere registered with a diagnosis of lung cancer
before death during the study year. The sampling procedure (one
in three ofunder-75s and one in seven ofoxer-75s) gave 294 cases
under 75 vears and 48 cases oxer 75 vears - a total of342 patients.
Twentv-sexen were excluded as ineligible after the case note
reviex. leaxIin, 315 patients. Case notes were available for
2621315 of these patients (83%). 231 cases in the under-75 group
and 31 in the oxer-75 group. Where important differences in the
management of these txo age groups were apparent. the data are
presented separately. The age and sex distribution ofthe sample is
shown in Table 1.
The diagnosis of lunc cancer was often made after an abnormal
chest radiograph wxas found during investigation of an unrelated
problem. This group is described separately for some items. where
relevant. e.g. excluded for some of the time calculations. as thev
were often not referred bv letter. but seen as inpatient referrals:
they also had no symptoms to report. Denominators were often
less than 262. either for this reason or because of missing data:
they are reported explicitly for each item.
Time intervals between referral, hospital contact,
management decision and treatment
At first hospital contact 32%7 (66/208) of patients reported symp-
toms for less than 4 wxeeks and cumulatixely 69%7 (143/208) for
less than 3 months. Eightv-three per cent (159/192) were seen
within 2 wxeeks of initial referral. Patients presentinc with an
abnormal chest radiograph as an incidental findingr were excluded
from this item as described above. The median time from first
hospital contact to a management decision was 18 days (range
0-197) with 67% (153/228) having a decision made within 4
weeks offirst hospital contact. The median time interval from first
hospital contact to definitixe surgery was 63 days. There was a
significantly longer delay to surgery in 14 patients who wxere
initiallx referred to non-respiratory physicians (chi-square
statistic = 4.5. P = 0.03). This delay included a median 35 days to
bronchoscopv in this subgroup compared with a median 7 days for
all patients. Patients undergoing radical radiotherapy had a median
time interval of 70 day s from first hospital contact to commence-
ment oftreatment.
Clinical specialty of those involved in initial
management and treatment decisions
Initial referral xxas to a respiratorx physician in 57%7c ( 132/231 ) of
the under-75s and 45%c (14/31) of the over-75s. The initial
management decision was made by a respiratory physician in
82% (189/231) and 67%7 (21/31) of patients in these groups
respectively.
Resources (bed-days and procedures) utilized in the
diagnosis and initial management
Bronchoscopy was the commonest diagnostic test. wxith 80%
(184/231) of the under-75s and 55% (17/31) of the oxer-75s
Table 1 Age and sex of study population
Age (years) Men (%) Women (%) Total (%)
<45 1 2 3(1)
45-54 14 8 22 (8)
55-64 57 22 79 (30)
65-74 80 47 127 (49)
75-84 21 8 29 (11)
> 85 1 1 2 (1)
Total 174 (66) 88 (34) 262 (100)
Table 2 Histological confimiation following initial investigation
Age (years) Histological verfiation
Yes (% of age group) No Total in age group
<55 21 (84) 4 25
55-64 58 (73) 21 79
65-74 80 (63) 47 127
75-84 16(55) 13 29
> 85 1 (50) 1 2
Total 176 (67) 86 (33) 262 (100)
Table 3 Actual initial management adjusted for sampling procedure
Management No. of patients Per cent of total population
corected for age group
Supportive care 438 38.4
Palliative radiotherapy 196 17.2
Radical radiotherapya 29 2.5
Surgical assessmenta 127 11.2
Chemotherapy 117 10.2
Not known/notes not available 235 20.5
Total 1142 100
aThese are total numbers, therefore adjustment for sampling was not
required.
haxing this performed (chi-square statistic = 9.42. P = 0.002).
Thirt per cent (79/262) had pulmonarv function tests performed.
Computenrzed tomographic (CT) scans of thorax were performed
in 28% of patients (75/262) before a management decision.
including the decision to refer for surgical assessment. was made.
Forty-nine per cent ( 1 14/231 ) of patients aged under 75 years and
67% (21/31) of oxer-75s had inpatient investigations. requiring
2304 bed-days (median 14 days. range 1-96).
Patients referred for surgical assessment commonly had further
investications performed followxxcg referral to the surgeon. CT
scanninc and/or mediastinoscopy was performed as part of the
surgical assessment. either by refemrng physicians or by surgeons.
in 81% (92/114). with 65% (74) having CT. 35% (40) medi-
astinoscopy and 18%7 (21 ) both.
Histological confirmation rates and distribution of cell
types
Histological confirmation Aas obtained in 699% (176/262) of
cases. but in decreasing proportions of each age band (Table 2).
When histology was obtained. 79% (139/176) of tumours xxere
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Figure 1 Survival after surgery and radical radotherapy for lung caner,
Glasgow 1991-92
non-small cell lung cancer (NSCLC). 21% (37/176) small cell
lung cancer (SCLC).
Actual initial management
Actual initial management for the whole cohort, corrected for the
different sample size and thus giving information which applies to
the whole Glasgow population with lung cancer diagnosed in life
(n = 1142), is shown in Table 3.
Surgical group
Ninety per cent (114/127) of case records of patients referred for
surgical assessment were available. Sixty-one patients had defini-
tive surgery during the study year, representing 5% of the whole
lung cancer population. Thirty-nine patients, 64% ofthose having
definitive surgery. were disease free at 3-year follow-up.
Radiotherapygroup
Twenty-nine patients in Glasgow (2.5%) received radical radio-
therapy for lung cancer during the study year. The records of 27
patients were available for review. Twenty-four had planning CT
performed. Twenty-four patients received a tumour dose which
would be considered radical, including two patients who were
treated following surgery (4978 cGy in 19 fractions and 6250 cGy
in 25 fractions). Of the three patients who received a lesser dose,
one had treatment interrupted after receiving 220 cGy and there
was no explanation in the notes for the two remaining patients. By
3 years, 13 patients had had suspected local recurrence, nine had
metastatic disease and five had been lost to follow-up. Only one
patient was definitely alive.
Chemotherapygroup
In the study sample, 39 patients received chemotherapy. Case
notes relating tochemotherapy treatment were available forreview
in 23 cases, infonnation on chemotherapy being culled from
cancer therapy network registers or letters in other hospital case
notes. Twenty of these (87%) had histological confirmation, of
whom the majority had SCLC. Overall, 117 (10.2%) ofthe whole
population were calculated to have received chemotherapy. Most
patients with SCLC receiving chemotherapy were treated with
standard regimens.
Survival
Ofthe 238 patients (91%) who had died by 3 years afterdiagnosis,
211 (89%) deaths were recorded as due to lung cancer. 12 to
another tumour and 15 to other causes.
No difference in survival was seen by cell type (data not
shown), or between the two age groups or by area of residence.
Figure 1 shows the survival of patients treated by surgery and
radical radiotherapy and reveals that the survival of patients
treated by surgery was significantly better.
DISCUSSION
This study describes the process and outcome of care for a cohort
of patients diagnosed with lung cancer in 1991-92. Based on
cancer registration data it is the closest to a cross-sectional study
which can be achieved. Fmdings can therefore be used to inform
service planning and can be compared with previous surveys based
on cancer registrations (Connolly et al, 1990; Watkin et al. 1990).
A third ofpatients reported symptoms for less than 4 weeks, but
31% had had symptoms for more than 3 months. highlighting the
need for a low threshold for arranging chest radiographs in at-risk
patients with persistent symptoms and offering the prospect of
earlier diagnosis.
Significant positive findings include the short time interval from
referral to first hospital contact and the median 18 days from first
contact to the making of a management decision. The date of
management decision was a useful milestone as it took account of
the speed of response to bronchoscopic findings including
histology. These intervals are compatible with standards proposed
by the Standing Medical Advisory Committee (Whitehouse,
1994), although the wide range, also observed elsewhere, is less
acceptable (Billing and Wells, 1996).
Although initial referral was to respiratory physicians in less
than two-thirds of the under-75s, management decisions were
usually made by them, often afterbronchoscopy. General and care
ofthe elderly physicians were the decision makers for a significant
minority of over-75-year-old patients. It is possible that patients
under the care ofotherphysicians had their management discussed
with a respiratory physician but not recorded in the case note.
However, the significantly lower rate of bronchoscopic investiga-
tion in older patients and the decline in histological confirmation
rates with age may reflect the lesser involvement of respiratory
physicians. This differential has previously been observed else-
where (Brown et al, 1996). The greater involvement ofnon-respi-
ratory physicians documented is more likely to be identified in a
population-based study, such as this one, reflecting actual practice,
and not biased by selection of cases in studies based on the refer-
rals to individual specialists.
Significant negative aspects include the systematic lackofinfor-
mation on performance status or of formal tumour staging, which
limits the usefulness ofthe survival data reported.
Thirteen per cent of the study population was referred for
surgical assessment, which often included measurement of
pulmonary function and CT scanning, where this was not already
available. Practice in this regard may have changed with the greater
availability of CT scanning and emphasis on timely onward
referral, highlighted by the Whitehouse (1994) report. Although
relatively few patients had CT scans before surgical referral, 81%
of such patients had either CT scan or mediastinoscopy as part of
that assessment The surgical referral rate, distinct from that for
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definitive surgery. may have been underestimated where patients
were discussed informally at combined surgery/radiography meet-
ings without this being recorded in the case note.
Definitive surgery was undertaken in 5% of the study popula-
tion. The proportion is lower than in Merseyside (1974-86)
(Watkin et al, 1990), where 8.9% were trated surgically. In the
cohort identified prospectively from Edinburgh (Fergusson et al,
1996), the proposed reatment was surgery for 23% of patients
(144/622). However, ofthe 130patients whounderwent surgery, at
least 26 had pathological evidence of N2 disease after surgery,
indicating that surgery may not always have been targeted effec-
tively. In addition, that cohort only included patients referred to
specialists with a lung cancer interest. Neither ofthese studies has
sufficient data to comment on the appropriateness of surgical
assessment, but discrepancies exist between UK practice and that
in mainland Europe and North America where, however, denomi-
nators may be less reliable (Muers and Haward, 1996). As surgery
is widely accepted as affording the best prospect of long-term
survival, further study ofthe perceived low proportion ofpatients
having surgical assessment locally and more widely in the UK is
still required.
There was a median 63 days from first hospital contact to
surgery; this included a long (median 35 day) delay to broncho-
scopy in a subset of patients not initially referred to respiratory
physicians, compared with a median delay to bronchoscopy of 7
days overall. The other major source of delay occurred after
surgical referral, as the median delay between seeing the surgeon
and surgery was only 6 days. Patients in Glasgow are referred to
thoracic surgeons partly viajoint meetings at which case notes and
radiographs are transferred and partly by letter. The same
comments also apply to delays to radiotherapy. Another recently
reported study showed even longer delays, with a mean of 109
days fromfirst presentation tooperation (Billing andWells, 1996).
Tlere may be a role for administrative staffwith responsibility for
progress chasing ofsuch patients, akin to transplant coordinators.
Care by a multidisciplinary team, which has been shown to be
effective in other cancers (Junor et al, 1994), may also have a role
in lung cancer. This would involve respiratory physicians who can
organize bronchoscopy and early review. However, even fast
tracking of such patients does not prevent delays to treatnent, as
opposed to diagnosis (Deegan et al, 1996).
The poor outcome in patients trated with radical radiotherapy
is disappointing, although difficult to interpret without informa-
tion on tumour staging and performance status. This reinforces the
need forprospectively collected data on such matters.
The proportions of different histological types and the use of
different treatment modalities are bxoadly similar to those reported
elsewhere but areconfirmed here in acompletely unselected cohort
The median 14 days of inpatient investigation is possibly
skewed by data from patients admitted for other reasons, despite
investigation days being counted only from the day of first
mention oflung cancer. The data also refer to a period when day-
case bronchoscopy was uncommon in Glasgow.
The overall survival rate is similar to that reported elsewhere
(Connolly et al, 1990, Watkin et al, 1990), and no relationship with
area of residence is seen. It is possible that patients from different
socioeconomic backgrounds present at different stages, but there
was no difference in the surgical rate of these groups (data not
shown), which would argue against this as amajorfactor. There is a
need forcloserscnitiny ofpotential surgical cases, in orderto assess
both appDroiateness ofcare and possible differences in outcome.
In summary, this study has described the care given to a recent
cohort oflung cancer patients in Glasgow. It provides population-
based data on the process ofcare and documents the typically poor
overall survival rate. The surgical resection rate was low, but in
this subgroup survival was 64% at 3 years. The survival data for
patients having radical radiotherapy cannot be interpreted without
further information, although they do suggest that performance
status and disease extent may have been imperfectly assessed.
The study has identified areas where good practice is routinely
being provided but has alsohighlighted problem areas. The lack of
performance status or tumour staging information relates to the
method ofretrospective case note review, which also suffers from
the common problem ofnon-availability ofcase notes for review.
Thne low proportion receiving chemotherapy or definitive surgery
and the poor outcome after radical radiotherapy indicate the need
for ongoing audit, which should include information on tunour
stage and performance status, in order to assess the appropriate-
ness ofsuch rates.
Specialist multidisciplinary clinics, at which patients with a
possible diagnosis of lung cancer could be seen quickly, would
favour the systematic collection of audit data and encourage the
making ofappropriate management decisions, including participa-
tion in clinical trials. The case for administrative support staff
could be better justified, if they were responsible for a sizeable
number ofpatients; they could ensure that patients were presented
for radical treatment promptly, as well as providing a channel of
communication for ongoing support and palliative care of others.
The findings of this audit suggest that improvements in care are
still possible, particularly forolderpatients; organizational barriers
to good care currently exist and specialist clinics with dedicated
staffmerit further investigation.
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